Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Advancement Flap Technique for Anal Fistula in Patients With Crohn's Disease...
Journal Information
Vol. 95. Issue 10.
Pages 558-565 (December 2017)
Visits
4235
Vol. 95. Issue 10.
Pages 558-565 (December 2017)
Review article
DOI: 10.1016/j.cireng.2017.09.008
Full text access
Advancement Flap Technique for Anal Fistula in Patients With Crohn's Disease: A Systematic Review of the Literature
Resultados del tratamiento quirúrgico de la fístula anal en pacientes con enfermedad de Crohn mediante técnica de colgajo de avance endorrectal: revisión sistemática de la literatura
Visits
...
Virginia Rozalén, David Parés
Corresponding author
dapares@gmail.com

Corresponding author.
, Edward Sanchez, José Troya, Sandra Vela, Miguel Ángel Pacha, Marta Piñol, Joan-Francesc Julián
Unidad de Cirugía Colorrectal, Servicio de Cirugía General y Digestiva, Hospital Germans Trías i Pujol, Universitat Autónoma de Barcelona, Badalona (Barcelona), Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (4)
Table 1. Characteristics of the Studies Included in the Systematic Review.
Table 2. Details of the Surgical Technique and the Treatment in Each Series Published.
Table 3. Characteristics of the Patients of Each Study Included in the Systematic Review.
Table 4. Clinical Results in all the Patients Included in the Systematic Review.
Show moreShow less
Abstract
Introduction

Treatment for anal fistulas in patients with Crohn's disease is still challenging, even for the expert surgeon. The advancement flap technique is characterized by the preservation of the anal sphincter complex.

Methods

A systematic review of the literature, selecting series of patients affected by Crohn's disease and anal fistulas and treated using advancement flap technique was performed. Patients followed during at least 6 months have been included.

Results

From 128 initial studies, 11 studies were selected, including overall 135 patients. Those studies show low-level evidence. Results in a series with follow-up from 8.4 to 82 months, stated a clinical success of 66% and recurrence rate around 30%. However there was an evident heterogeneity of results.

Conclusion

The review concludes that the advancement flap technique to treat anal fistulas in patients with Crohn's disease is an adequate alternative. New studies are necessary to provide higher-level evidence.

Keywords:
Anal fistula
Crohn's disease
Advancement flap
Results
Resumen
Introducción

La técnica de colgajo de avance endorrectal es una de las alternativas en el tratamiento de la fístula anal en pacientes con enfermedad de Crohn.

Métodos

Diseñamos una revisión sistemática de la literatura, seleccionando estudios que incluyeron a pacientes afectos de enfermedad de Crohn y fístula anal tratados mediante esta técnica. De esos estudios solo se seleccionaron los pacientes seguidos durante al menos 6 meses.

Resultados

Se seleccionaron 11 estudios con un total de 135 pacientes. Los resultados, con seguimientos de 8,4 a 82 meses, indicaron una curación del 66% y una tasa de recurrencia de alrededor del 30%. Sin embargo, se observó importante heterogeneidad en los resultados de las series revisadas.

Conclusiones

El colgajo de avance endorrectal es una alternativa adecuada en los pacientes con fístula anal y enfermedad de Crohn. Sin embargo, es necesario desarrollar nuevos estudios que aporten un mayor nivel de evidencia científica.

Palabras clave:
Fístula anal
Enfermedad de Crohn
Colgajo de avance
Resultados
Full Text
Introduction

The surgical management of anal fistulae is a real therapeutic challenge.1 Although most patients present anal fistulae that can be treated with a fistulotomy technique, providing satisfactory results in terms of recurrence and short-term and long-term functional problems (fecal incontinence), there are patients with complex anal fistulae that require techniques to preserve the anal sphincter complex.2 This situation is especially difficult in patients with Crohn's disease. There are different surgical options to reportedly preserve the sphincter complex, such as the endorectal advancement flap and the LIFT technique, or the use of plugs, fibrin sealants and even stem cells.3

Crohn's disease can frequently present perianal involvement, in many cases with the appearance of very complex fistulae4 and a clinical scenario that can become particularly difficult to manage surgically. Once the treatment of the underlying disease has been carried out with an existing drug (for example, anti-TNF), the controversy lies in which type of surgical technique should be used in these patients to treat the anal fistula.5

Among all the technical alternatives, the endorectal advancement flap has been shown to be an appropriate treatment for patients with anal fistulae in this clinical situation.6 However, although there is scientific evidence of its usefulness in cryptoglandular anal fistulae,7 there are still few results about the use of this technique in patients with Crohn's disease.

The objective of this study was to systematically review the literature in order to determine the clinical results published for the surgical treatment of anal fistulae in patients with Crohn's disease using the endorectal advancement flap technique.

MethodsStudy Design

A study protocol was designed to conduct a systematic review of the literature, following standardized methods of analysis and eligibility in accordance with the PRISMA8 and QUORUM9 guidelines, also using the new reporting elements derived associated with PRISMA (harms checklist 2016).10

Search Strategy and Selection CriteriaStudy Characteristics

The characteristics and objective of the study were defined using a methodology following the PICO scheme. The definitions of the search terms were inclusive to promote a search for studies that reported clinical results in series of patients with Crohn's disease, in whom the endorectal advancement flap technique had been performed (also called “mucosal flap,” “mucosal-muscle flap” or “total thickness”) to treat primary or recurrent perianal fistulae.

PopulationInclusion Criteria

MESH-type search terms were used, including: patients over 18 years of age, of either sex, with a confirmed diagnosis of Crohn's disease and perianal disease in the form of an anal fistula. The specific search terms were: “anal fistula,” “Crohn's disease” and “advancement flap.” Likewise, an iterative focus by cross-reference was necessary to ensure that all terms in common use were incorporated into the search strategy.

Exclusion Criteria

Patients previously treated with resections of the rectum of any magnitude or etiology were excluded from the published series. Some studies presented results in patients with perianal fistula of different etiology (cryptoglandular origin and Crohn's disease), of which only those of the interest group were included. When these data could not be separated by groups, the study was considered not eligible for inclusion. A minimum population sample was not considered necessary for the eligibility of the study, but a minimum clinical follow-up of 6 months after surgery was required.

Sources of Information (Bibliographic Search)

The main authors conducted a detailed search of the literature, including all articles published before March 6, 2017 using the PubMed, Spanish Medical Index, Cochrane Library and Scopus bibliographic databases. The search terms used a sensitive combination of population terms, interventions and keywords.

Variables Studied

The studies were eligible if they provided extractable data about the clinical benefits of the technique (cure rates). The studies needed to report fistula recurrence data, defined as the clinical reappearance (and in some cases with radiological verification by MRI or endoanal ultrasound) of the lesions during the follow-up period. For the evaluation of the complications derived from the surgical intervention, we contemplated postoperative fecal continence data and the need to perform a stoma during the follow-up of these patients, following similar previous studies.7

Study Types

Our review only included studies with a full text in English or Spanish. Only studies that reported clinical data from patient series were eligible for review, regardless of whether they were descriptive or analytical studies, or with prospective or retrospective data collection. For this reason, literature review articles, editorials, letters and other forms of secondary expert opinion were excluded from the final selection of articles. Only full text studies were eligible. Thus, abstracts, conference proceedings or incomplete documents were also excluded from the search. No restriction was imposed based on the level of scientific evidence. This decision was made with the knowledge that the vast majority of the data would be extracted from case series and not from higher-quality study types.

Study Selection

The selection was made in an initial stage through the reading of abstracts by the authors. Studies that did not meet the eligibility criteria were excluded. Full text copies in English or Spanish were obtained for all the studies and evaluated by the authors. With the results of the initial search, other references of the selected studies were identified to expand the number of eligible studies, leading to a second search. Two authors carried out searches independently, which were later compared. In the articles in which there was controversy regarding their inclusion, the decision was made as a consensus.

Evaluation of the Methodological Quality

The methodological quality of all included studies was assessed by the authors and classified according to Oxford CEBM 200910 scientific level of evidence definitions. The following rules were applied, accepting that distinguishing between study designs can be problematic when it comes to observational studies.11

Surgical Technique

We focused on identifying studies of patients with Crohn's disease and perianal fistula who underwent surgery with the endorectal advancement flap technique. In order not to lose relevant information, we also included studies of patients operated on with this surgical technique in combination with some other type of variation in the technical procedure or added medical therapy related to their perianal disease.

The flap or endorectal advancement flap technique involves closing the internal orifice and covering it with an endorectal mucosal/submucosal flap of the rectal/anal wall, affixed with sutures. In addition to the thickness used (mucosal flap or mucosal-muscle flap), there are several technical variations that may include different suture types (absorbable vs non-absorbable) as well as the possible completion of a fistulectomy of the tract from the external orifice to the sphincter complex.12,13

Statistical Analysis

The variables registered were described with appropriate descriptive statistics (absolute numbers or percentages, mean or medians, ranges or standard deviation). The synthesis of quantitative data was analyzed by results, using Excel for Windows® and SPSS® program 21.0.

ResultsSelected Studies

The initial search identified 122 potentially relevant studies (59 in PubMed, 28 in the Spanish Medical Index and 35 in Scopus). Six articles were excluded because they were duplicates, but 6 additional articles were identified by cross-references. Out of the 128 that were eligible, 81 were excluded because the title and abstract did not meet the established inclusion criteria.

Out of the 47 remaining articles selected for the review and for which full texts were obtained, another 36 were excluded because many reported rectovaginal fistula data (n=12), did not present clinical information of interest for the review (n=10) or simply did not show data in order to perform the analysis designed (n=6). Other articles were also excluded in this phase because they treated pediatric patients (n=1), patients without Crohn's disease (n=1) and one due to a short follow-up period of only 3 months. Finally, articles written in a language other than Spanish or English were discarded (n=2) along with studies that referred to another surgical technique (n=3). Therefore, a total of 11 studies were included in the final selection, as shown in the flow chart of Fig. 1.

Fig. 1.

Flow diagram showing the studies included in the systematic review.

(0.28MB).
Characteristics of the Studies

The detailed characteristics of the studies included in the review are shown in Table 1. Eleven studies were selected that were published between 1987 and 2015, which reported clinical data of a total of 749 patients. Five of these studies were from the United States, 3 from the Netherlands and the remainder from Italy, Germany and the United Kingdom (Fig. 2).

Table 1.

Characteristics of the Studies Included in the Systematic Review.

Author  Year  Sample size  Patients included  Study type  Data analysis  Level of evidence 
Jones et al.25  1987  39  Case series  Prospective  2C 
Shemesh et al.28  1988  Case series  Prospective  2C 
Lewis et al.29  1990  Case series  Prospective  2C 
Makowiec et al.30  1995  32  20  Case series  Prospective  2C 
Hyman et al.26  1999  33  14  Case series  Prospective  2C 
Van der Hagen et al.14  2006  103  12  Case series  Prospective  2C 
Gaertner et al.16  2007  226  Case series  Retrospective  2C 
Van Koperen et al.15  2009  61  Case series  Prospective  2C 
El-Gazzaz et al.17  2012  218  39  Case series  Retrospective  2C 
Schwandner18  2013  11  10  Case series  Prospective  2C 
Göttgens et al.19  2015  10  10  Case series  Prospective  2C 
Total749  135       
Fig. 2.

The relationship between the cure % of anal fistula using the endorectal advancement flap in patients with Crohn's disease and the year of publication of the series.

(0.05MB).

Out of the 749 patients described, 135 patients met the inclusion criteria and the rest were excluded as they were patients with fistulae of cryptoglandular origin or non-anal fistulae (rectovaginal, rectourethral).

All the studies were case series. The majority had prospective data collection, except for 2 that were retrospective with a 2C level of scientific evidence, as shown in Table 1.

Surgical Technique

The studies by Van der Hagen et al.14 and Van Koperen et al.15 evaluated the use of endorectal advancement flaps as a surgical treatment for perianal fistulae involving the upper 2/3 of the anal sphincter and fistulotomy for the lower third, so we collected the data pertaining to the variables of interest.

Two studies (Gaertner et al.16 and El-Gazzaz et al.17) evaluated patients treated with biological therapy (anti-TNF), in addition to the surgical option, and compared them with patients treated with surgery alone. Among the surgical interventions performed were treatments with seton drainage, fistulotomy, fibrin glue, collagen plug, perineal repair and advancement flap. Both studies were retrospective.

The study by Schwandner et al.18 made the diagnosis with the help of video-assisted anal fistula treatment (VAAFT) prior to the completion of the advancement flap and, in some of their patients, biological therapy. Göttgens et al.19 combined the advancement flap treatment with instillation of platelet-rich plasma through the fistulous tract.

As there was some variation in the technical aspects, Table 2 specifies what the technique involved or the treatment added to the surgery and its correlation with the clinical results obtained.

Table 2.

Details of the Surgical Technique and the Treatment in Each Series Published.

Author  Added treatment  Surgical technique 
Jones et al.25  None  Mucosal-muscle flap 
Shemesh et al.28  None  Mucosal-muscle flap 
Lewis et al.29  None  Mucosal-muscle flap 
Makowiec et al.30  None  Mucosal-muscle flap 
Hyman et al.26  None  Mucosal-muscle flap 
Van der Hagen et al.14  None  Mucosal flap 
Gaertner et al.16  Infliximab (66.7%)  Mucosal flap 
Van Koperen et al.15  None  Mucosal flap 
El-Gazzaz et al.17  Infliximab/adalimumab (38.4%)  Not specified 
Schwandner18  VAAFT (100%)+infliximab/adalimumab (50%)  Mucosal-muscle flap 
Göttgens et al.19  Platelet-rich plasma  Mucosal flap 
Patient Characteristics and Follow-Up

The studies reported limited patient series, with a minimum of 4 and a maximum of 39 patients. Only in 3 studies was the follow-up performed with MRI.14,17,19Table 3 shows the characteristics of age, gender and time of follow-up for each study. Due to the prevalence of Crohn's disease, most of the series were of young patients with an average age ranging between 33 and 47 years. The proportion of women in each study was very variable (from 27.3% to 75%).

Table 3.

Characteristics of the Patients of Each Study Included in the Systematic Review.

Author  No. of patients analyzed  Agea  Women (%)  Follow-upb 
Jones et al.25  38  74  25 (3–67) 
Shemesh et al.28  47  75  NR (12–60) 
Lewis et al.29  33  50  NR (2–24) 
Makowiec et al.30  20  31.8  56  19.5 (SD: 12.1) 
Hyman et al.26  14  39.7  66.7  39 (3–90) 
Van der Hagen et al.14  12  37  36.6  72 (48–99) 
Gaertner et al.16  39  27.3  30 (6–216) 
Van Koperen et al.15  36  59  82 (17–132) 
El-Gazzaz et al.17  39  38.8  62  38 (2.4–74) 
Schwandner18  10  33  60  8.4 (6–9) 
Göttgens et al.19  10  47  70  23.3 (SD: 13) 
Total  135       

NR, data not reported.

a

Mean age (yrs).

b

Mean follow-up and range in months (SD, standard deviation).

The follow-up after surgery was also very heterogeneous and ranged from 8.4 to 82 months post-op. Two of the studies included did not report mean follow-up time but instead used time ranges.

Results

Table 4 describes the clinical results of the surgery. The cure percentages varied from 33.3% to 100% with a global average of 66.7%. In 2 of the studies, it was not possible to isolate the data of the patients of interest with regards to the cure rate. The postoperative anal fistula recurrence rates ranged from 0% to 66.7%, with a global mean recurrence of 30%.

Table 4.

Clinical Results in all the Patients Included in the Systematic Review.

Author  Cure (%)  Recurrence (%)  Fecal incontinence (%)  Stoma (%) 
Jones et al.25  33.3  66.7  NR 
Shemesh et al.28  100  NR  NR 
Lewis et al.29  83.3  16.7  NR 
Makowiec et al.30  NR  20  NR 
Hyman et al.26  71.4  21.4 
Van der Hagen et al.14  NR  33.3  NR 
Gaertner et al.16  50  NR  NR  NR 
Van Koperen et al.15  44.4  55.6  66.7  NR 
El-Gazzaz et al.17  68  NR  NR  NR 
Schwandner O.18  80  20  30 
Göttgens et al.19  70  30  NR  10 

NR, data not reported.

Not all studies reported data on fecal continence or the need for a stoma during follow-up. The study by Van Koperen et al.15 reported 66.7% fecal incontinence and is the study with the longest mean clinical follow-up. Five of the studies analyzed reported 0% postoperative fecal incontinence. In the 4 studies that described the creation of a stoma in patients with poor clinical evolution, this situation was necessary in 0%, 10% and 30% of cases.

Discussion

Systematic reviews of the literature provide relevant clinical information, especially in those aspects of surgery in which it is very difficult to adequately conduct studies with a large number of patients. The surgical management of anal fistula in patients with Crohn's disease is an example. This was the reason for designing this systematic review of the literature, including the articles published during the last 30 years in Spanish and English about the clinical results of the advancement flap surgical technique in these patients. The result allowed us to select 11 articles and conclude that the results for cure are around 65%.

To our knowledge, this is the first systematic review of the literature that analyzes this therapeutic alternative only in patients with Crohn's disease and, although the strict selection criteria have allowed us to obtain valuable information, the study has certain limitations. The clinical series obtained are very heterogeneous (in number of patients and technique variations), with studies that provide a low level of scientific evidence. We therefore could not use meta-analysis techniques because the data were not very solid. Thus, the conclusions and the information analyzed have limited value in certain aspects. However, this review allows us to affirm, without forgetting its limitations, that this surgical technique should be considered an alternative in patients with Crohn's disease.

Interestingly, the published articles provide different technical aspects in addition to the advancement flap, such as the adjuvant use of treatments or associated maneuvers (for example, VAAFT18). However, there is little consensus as to the need or not of mechanical preparation of the colon or the use of antibiotics. Although these maneuvers are less controversial in cryptoglandular fistulae,2 in the context of Crohn's disease, which is still medically controlled, it is a different situation.

The analysis of complications after surgery for anal fistula of cryptoglandular origin, especially the appearance of postoperative fecal incontinence, has been fundamental in recent years.20,21 For this reason, we were interested in adding this secondary objective, especially in patients with Crohn's disease, since although the disease is controlled with medical treatment, the history of previous surgeries can cause altered bowel rhythm in the form of diarrhea and, therefore, a theoretical higher risk of incontinence.22 However, this datum was present in only 3 series and with very different data.

As a result indicator, we wanted to analyze (similar to other series) the need for creating a stoma in the evolution of complex anal fistulae, especially in patients with Crohn's disease. However, this datum acquires a different relevance in the clinical scenario of revision due to the presence of the disease.23,24 This datum was collected in 4 series: in 2 the stoma was not necessary in any case,25,26 while in the others it was necessary in 10%19 and in 30%,18 respectively.

During the completion of this review study, we found that there is little adequate literature on the treatment of perianal fistula using the advancement flap technique in patients with Crohn's disease, and the studies provide a low level of evidence (2C). For this reason, multicenter prospective and randomized studies should be designed to compare endorectal advancement flap with the other surgical techniques described (for example, LIFT27). In a study of these characteristics, it would be necessary to establish whether patients require medical treatment associated with their Crohn's disease due to the evidence of their effectiveness in the results.5

In conclusion, the results data of the treatment of complex anorectal fistulae in patients with Crohn's disease with endorectal advancement flap present a low level of evidence. In spite of this, the technique is recognized as a good alternative for the surgical management of anal fistula. It is therefore worth mentioning the need for specialized units to develop multicenter clinical trials that provide high-level evidence on the treatment of complex fistula in patients with Crohn's disease.

Conflict of Interests

The authors have no conflict of interests to declare.

References
[1]
J.G. Williams, P.A. Farrands, A.B. Williams, B.A. Taylor, P.J. Lunniss, P.M. Sagar, et al.
The treatment of anal fistula: ACPGBI position statement.
Colorectal Dis, 9 (2007), pp. 18-50
[2]
S.R. Steele, R. Kumar, D.L. Feingold, J.L. Rafferty, W.D. Buie.
Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of perianal abscess and fistula-in-ano.
Dis Colon Rectum, 54 (2011), pp. 1465-1474
[3]
M.J. Lee, N. Heywood, P.M. Sagar, S.R. Brown, N.S. Fearnhead.
Surgical management of fistulating perianal Crohn's disease – a UK survey.
Color Dis, 19 (2017), pp. 266-273
[4]
S. Duff, P.M. Sagar, M. Rao, S. Dolling, M. Sprakes, P.J. Hamlin.
Infliximab and surgical treatment of complex anal Crohn's disease.
Colorectal Dis, 14 (2012), pp. 972-976
[5]
P. Gionchetti, A. Dignass, S. Danese, F.J. Magro Dias, G. Rogler, P.L. Lakatos, et al.
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical management and special situations.
J Crohns Colitis, 11 (2017), pp. 135-149
[6]
P. Tozer, D.W. Borowski, A. Gupta, N. Yassin, R. Phillips, A. Hart.
Managing perianal Crohn's fistula in the anti-TNFα era.
Tech Coloproctol, 19 (2015), pp. 673-678
12
[7]
Z. Balciscueta, N. Uribe, I. Balciscueta, J.C. Andreu-Ballester, E. García-Granero.
Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis.
Int J Colorectal Dis, 32 (2017), pp. 599-609
[8]
A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P.A. Ioannidis, et al.
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
J Clin Epidemiol, 62 (2009), pp. e1-e34
[9]
D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, D.F. Stroup.
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement, quality of reporting of meta-analyses.
Lancet, 354 (1999), pp. 1896-1900
[10]
L. Zorzela, Y.K. Loke, J.P. Ioannidis, S. Golder, P. Santaguida, D.G. Altman, et al.
PRISMA harms checklist: improving harms reporting in systematic reviews.
BMJ, 352 (2016), pp. i157
[11]
O.M. Dekkers, M. Egger, D.G. Altman, J.P. Vandenbroucke.
Distinguishing case series from cohort studies.
[12]
C. Ruffolo, M. Scarpa, N. Bassi, I. Angriman.
A systematic review on advancement flaps for rectovaginal fistula in Crohn's disease: transrectal vs transvaginal approach.
Colorectal Dis, 12 (2010), pp. 1183-1191
[13]
Z. Balciscueta, N. Uribe, I. Balciscueta, J.C. Andreu-Ballester, E. García-Granero.
Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis.
Int J Colorectal Dis, 32 (2017), pp. 599-609
[14]
S.J. Van der Hagen, C.G. Baeten, P.B. Soeters, W.G. van Gemert.
Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas.
Int J Colorectal Dis, 21 (2006), pp. 784-790
[15]
P.J. Van Koperen, F. Safiruddin, W.A. Bemelman, J.F.M. Slors.
Outcome of surgical treatment for fistula in ano in Crohn's disease.
Br J Surg, 96 (2009), pp. 675-679
[16]
W.B. Gaertner, A. Decanini, A. Mellgren, A.C. Lowry, S.M. Goldberg, R.D. Madoff, et al.
Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?.
Dis Colon Rectum, 50 (2007), pp. 1754-1760
[17]
G. El-Gazzaz, T. Hull, J.M. Church.
Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
Color Dis, 14 (2012), pp. 1217-1223
[18]
O. Schwandner.
Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn's disease.
Tech Coloproctol, 17 (2013), pp. 221-225
[19]
K.W. Göttgens, R.R. Smeets, L.P. Stassen, G.L. Beets, M. Pierik, S.O. Breukink, et al.
Treatment of Crohn's disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study.
Tech Coloproctol, 19 (2015), pp. 455-459
[20]
A.F. Engel, P.J. Lunniss, M.A. Kamm, R.K. Phillips.
Sphincteroplasty for incontinence after surgery for idiopathic fistula in ano.
Int J Colorectal Dis, 12 (1997), pp. 323-325
[21]
J. Garcia-Aguilar, C. Belmonte, W.D. Wong, S.M. Goldberg, R.D. Madoff.
Anal fistula surgery. Factors associated with recurrence and incontinence.
Dis Colon Rectum, 39 (1996), pp. 723-729
[22]
L. Dibley, C. Norton.
Experiences of fecal incontinence in people with inflammatory bowel disease.
Inflamm Bowel Dis, 19 (2013), pp. 1450-1462
[23]
A.C. Bafford, A. Latushko, N. Hansraj, G. Jambaulikar, L.J. Ghazi.
The use of temporary fecal diversion in colonic and perianal Crohn's disease does not improve outcomes.
Dig Dis Sci, 62 (2017), pp. 2079-2086
[24]
M. Martí-Gallostra, P. Myrelid, N. Mortensen, S. Keshav, S.P.L. Travis, B. George.
The role of a defunctioning stoma for colonic and perianal Crohn's disease in the biological era.
Scand J Gastroenterol, 52 (2017), pp. 251-256
[25]
I.T. Jones, V.W. Fazio, D.G. Jagelman.
The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum.
Dis Colon Rectum, 30 (1987), pp. 919-923
[26]
N. Hyman.
Endoanal advancement flap repair for complex anorectal fistulas.
Am J Surg, 178 (1999), pp. 337-340
[27]
D.S. Gingold, Z.A. Murrell, P.R. Fleshner.
A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease.
Ann Surg, 260 (2014), pp. 1057-1061
[28]
E.I. Shemesh, I.J. Kodner, R.D. Fry, D.M. Neufeld.
Endorectal sliding flap repair of complicated anterior anoperineal fistulas.
Dis Colon Rectum, 31 (1988), pp. 22-24
[29]
P. Lewis, D.C. Bartolo.
Treatment of trans-sphincteric fistulae by full thickness anorectal advancement flaps.
Br J Surg, 77 (1990), pp. 1187-1189
[30]
F. Makowiec, E.C. Jehle, H.D. Becker, M. Starlinger.
Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease.
Br J Surg, 82 (1995), pp. 603-606

Please cite this article as: Rozalén V, Parés D, Sanchez E, Troya J, Vela S, Pacha MÁ, et al. Resultados del tratamiento quirúrgico de la fístula anal en pacientes con enfermedad de Crohn mediante técnica de colgajo de avance endorrectal: revisión sistemática de la literatura. Cir Esp. 2017;95:558–565.

Copyright © 2017. AEC
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos